Tyrosine kinase-IN-8
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Tyrosine kinase-IN-8
UNSPSC Description:
Tyrosine kinase-IN-8 (compound 4e) is a BCR‐ABL1 tyrosine kinase inhibitor (TKI). Tyrosine kinase-IN-8 shows anti-proliferative activity against K562 cells, a chronic myeloid leukemia (CML) cell line (CC50=0.8 µM). Tyrosine kinase-IN-8 can be used in the study of chronic leukemia[1].Target Antigen:
Bcr-AblType:
Reference compoundRelated Pathways:
Protein Tyrosine Kinase/RTKApplications:
Cancer-Kinase/proteaseField of Research:
OthersAssay Protocol:
https://www.medchemexpress.com/tyrosine-kinase-in-8.htmlSolubility:
10 mM in DMSOSmiles:
CC(C=CC(N1C(C2=CC=C(F)C=C2)=NOC13C(C=C(F)C=C4)=C4NC3=O)=C5)=C5NC6=NC(C7=CC=CN=C7)=CC=N6Molecular Weight:
561.54References & Citations:
[1]de Azevedo L D, et al. Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells[J]. Archiv der Pharmazie, 2024: e2400029.Shipping Conditions:
Room temperatureClinical Information:
No Development Reported
